Bristol-Myers Escapes Abilify Movement Disorder Suit

Law360, New York (December 5, 2013, 6:13 PM EST) -- A Pennsylvania federal judge on Monday dismissed a man's lawsuit against Bristol-Myers Squibb Co. over a movement disorder he developed after taking the drug Abilify, saying that drugmakers are not required to provide detailed instructions to physicians about monitoring for adverse reactions.

Plaintiff Ryan Bergstresser claimed that Bristol-Myers failed to provide information in Abilify's package insert about monitoring for dystonia, a muscular disease marked by involuntary muscle contractions. Bergstresser allegedly suffers from permanent dystonia caused by Abilify he took to treat his depression.

U.S. District Judge...
To view the full article, register now.